BioMarin’s Roctavian & Argenx’s Efgartigimod Among Eight Hopefuls Awaiting EU Verdict

 
• By Vibha Sharma
  
Red stamp and an imprint EMA (European Medicines Agency) on white surface. EMA is an agency of the EU in charge of the evaluation and supervision
Its decision time for drugs at the EMA’s CHMP meeting • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography